Based on this year’s review, we have decided to discontinue offering Medicare Advantage (MA) products in six states beginning with the 2025 Annual Enrollment Period. We will be exiting Alabama, Massachusetts, New Hampshire, New Mexico, Rhode Island and Vermont. Wellcare will continue to offer Prescription Drug Plans in these states, and this decision does not impact our Marketplace or Medicaid contracts in these markets.

While our state footprint is changing, our commitment to delivering quality care and services to our members remains strong. The changes outlined above do not impact current members’ plans or benefits, and Wellcare will continue serving MA members in these six states through the end of 2024 and beyond for any contract run-out functions. Members will be notified in accordance with the Centers for Medicare and Medicaid Services (CMS) guidelines as part of the annual notification of change process. All enrollment materials related to these plans have been removed from Wellcare sites and enrollment platforms, and materials are no longer available for downloading, printing or ordering.

Importantly, our commitment to all of our other Medicare markets remains strong and unchanged.

We want you to know this difficult decision was not made lightly but will enable us to better focus our strategy and resources, so we can continue transforming the health of the communities we serve, one person at a time – for years to come. 

It has been our privilege to partner with you in support of our members and these communities. We know there will be questions and want to assure you we will work through next steps together. If you have questions, please contact your local sales leader.